UK-Based AstraZeneca Admits Covid Vaccine's Rare Blood Clot Risk In Court For First Time AstraZeneca acknowledges in court that its Covid vaccine can cause a rare blood clotting condition, as families seek compensation in a multi-million-pound class action
